Navigation Links
Tomas Ganz, M.D., Ph.D., to present 2014 ASH E. Donnall Thomas Lecture
Date:7/22/2014

(WASHINGTON, July 22, 2014) The American Society of Hematology (ASH) will honor Tomas Ganz, MD, PhD, of the University of California Los Angeles with the 2014 E. Donnall Thomas Lecture for his groundbreaking research in iron homeostasis, including the discovery of the iron-regulatory hormone hepcidin and investigation of its roles in iron metabolism. This award, named after the Nobel Prize Laureate and past Society president E. Donnall Thomas, MD, recognizes pioneering research achievements in hematology that have represented a paradigm shift or significant discovery in the field.

Dr. Ganz will present his lecture, "Iron, Erythropoiesis, and Host Defense: A Mnage Trois," at 9:00 a.m. on Monday, December 8, at the 56th ASH Annual Meeting and Exposition in San Francisco. His lecture will explore the advances in understanding of homeostatic iron regulation and the iron-regulatory responses to the challenges of acute hemorrhage and acute infection. During his lecture, Dr. Ganz will discuss iron deficiency anemia and anemia of inflammation and will expand upon how their frequency may reflect an evolutionary compromise to provide sufficient iron for essential processes while avoiding the tendency of iron to promote microbial infections and cause tissue injury. He will further elucidate insights into several components of iron regulation and response and discuss how the hormone hepcidin is regulated by erythroferrone, interleukin-6, and, to a lesser extent, other cytokines in response to blood loss and infection. Dr. Ganz's lecture will also touch upon how, as understanding of systemic iron homeostasis and its disorders increases, biological targets for diagnostic and therapeutic applications will be identified.

Dr. Ganz has been the leading scientist in the effort to uncover the molecular basis of iron homeostasis and its disorders. He played a pivotal role in the discovery of hepcidin and continues to lead the way in the ongoing exploration of hepcidin's effects, regulation, and mechanism of action in iron metabolism. Dr. Ganz's scientific approach is based on diverse, sophisticated, and elegant experimental approaches, ranging from molecular analysis of gene and protein regulation in cell lines and transgenic mice, to histopathologic studies and assays of samples from human patients and experimental animals.

Dr. Ganz currently serves as Professor of Medicine and Pathology at the University of California Los Angeles (UCLA) where he also serves as Director of the Will Rogers Pulmonary Research Laboratory and Co-Director of the Center for Iron Disorders. He earned his PhD in Applied Physics from the California Institute of Technology and his medical degree from UCLA. After completing both his residency in internal medicine and fellowship in pulmonary medicine at UCLA, Dr. Ganz joined the UCLA Department of Medicine in 1983 and has remained there ever since.

The importance of Dr. Ganz's work is evidenced through the publication of his research in many high-impact journals, his involvement in prominent organizations, and his receipt of several prestigious awards. Dr. Ganz is a past president of the International BioIron Society and the recipient of its 2005 Marcel Simon Award for excellence in the research of genetic hemochromatosis. In 2006 he was elected to the American Association of Physicians. Dr. Ganz is also a past recipient of the UCLA Medical Alumni Association Medical Science Award. For many years he served as an Associate Editor of Blood, the journal of the American Society of Hematology.

"Through his discovery of hepcidin and subsequent study of its mechanism of action, Dr. Ganz has revolutionized the field of iron biology and has transformed the way scientists and clinicians study and treat iron and anemia-related diseases," said 2014 ASH President Linda J. Burns, MD, of the University of Minnesota. "ASH is pleased to be honoring Dr. Ganz for his work that has paved the way for development of new treatments for these disorders."


'/>"/>

Contact: Amanda Szabo
aszabo@hematology.org
202-552-4914
American Society of Hematology
Source:Eurekalert

Related medicine news :

1. Biomarker may identify neuroblastomas with sensitivity to BET bromodomain inhibitors
2. Michael DeBaun, M.D., M.P.H., and Robert P. Hebbel, M.D., to present 2014 ASH Beutler Lecture
3. ASH honors Kanti R. Rai, M.D., with Coulter Award for Lifetime Achievement
4. The Cosmetic Medic Announces Grand Opening of New Skin M.D., a Physician-Administered Anti-aging, Skincare, and Weight Loss Practice
5. St. Jude Childrens Research Hospital names James R. Downing, M.D., CEO
6. Barry A. Siegel, M.D., receives 2014 Benedict Cassen Prize for Research in Nuclear Medicine
7. Mathuram Santosham, M.D., receives 2014 Albert B. Sabin Gold Medal Award
8. Molly Carnes, M.D., receives inaugural Linda Joy Pollin Heart Health Leadership Award
9. Francis S. Collins, M.D., Ph.D., to speak at AMP 2014 Annual Meeting
10. BIDMCs Martin Pollak, M.D., elected to National Academy of Sciences
11. Boston Medical Center cardiologist Gary Balady, M.D., receives AHAs Paul Dudley White Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2017)... ... June 28, 2017 , ... The parent company ... in employee engagement. Omaha-based C&A Industries, a national leader in staffing and ... in North America for 2017. The annual award, issued by Achievers, ...
(Date:6/28/2017)... Church, VA (PRWEB) , ... June 28, 2017 , ... ... http://www.fdanews.com/fdaeumdregs      , No matter on which side of the Atlantic devicemakers ... medical device regulations they have to follow. , In addition to the full text ...
(Date:6/28/2017)... ... June 28, 2017 , ... Eating disorders have the highest mortality ... at least one person dies as a direct result from an eating disorder in ... qualified treatment providers. The iaedp Foundation meets this challenge by offering what has become ...
(Date:6/28/2017)... ... June 28, 2017 , ... American Farmer proudly announces the participation of ... winning television series, scheduled to broadcast fourth quarter 2017. American Farmer airs Tuesdays at ... supplier of garden pea seed. As demand grew, the small company located in Moscow, ...
(Date:6/28/2017)... (PRWEB) , ... June 28, 2017 , ... ... insurance management and financial planning assistance to clients in southern Montana, is announcing ... offered by Zoo Montana. , The outreach programs offered by Zoo Montana provide ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... , June 7, 2017  Novavax, Inc., (Nasdaq: ... of two Phase 2 trials of its RSV F protein ... child bearing age have been published in the journal ... have been shared in prior scientific conferences). The Company previously ... April 2014. Novavax is developing the RSV F Vaccine with ...
(Date:6/2/2017)... Mass. , June 2, 2017  NxStage Medical, ... renal care, today announced new findings demonstrating positive biochemical ... ® System One™. The data will be presented ... in Madrid, Spain . ... to Improve Home Dialysis Network in Europe ...
(Date:5/29/2017)...  Cellect Biotechnology Ltd. (NASDAQ: APOP ; TASE: ... functional selection of stem cells, today provided a corporate ... ended March 31 st , 2017. ... first quarter of 2017," said Dr. Shai Yarkoni, Chief ... treatment of the first blood cancer patient in the ...
Breaking Medicine Technology: